Grifols GRFS
NASDAQ GRFS
$7.43 -0.07 (-1.00%)
As of: Oct 22, 2026 · 2:13 PM EDT

Grifols (GRFS) Share-based Compensation (IS) (2015)

Updated

Analysis

Grifols (GRFS) Share-based Compensation (IS) (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,169.76 Bn 1,138.35 Bn 19.71 Bn -
2 Johnson & Johnson 648.06 Bn 567.92 Bn 17.30 Bn -
3 AbbVie 503.37 Bn 476.48 Bn 12.70 Bn -
4 Merck 365.39 Bn 319.77 Bn 12.21 Bn -
5 Novartis Ag 303.45 Bn 267.44 Bn 11.24 Bn -
6 Astrazeneca 269.03 Bn 242.72 Bn 12.86 Bn -
7 Amgen 242.08 Bn 197.48 Bn 7.24 Bn -
8 Gilead Sciences 194.88 Bn 169.07 Bn 6.22 Bn -
9 Pfizer 172.39 Bn 119.04 Bn 10.94 Bn -
10 Grifols 5.05 Bn 1.40 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 4.51 Mn
API Access

Grifols Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=GRFS&period=max&api_key=YOUR_API_KEY